Zobrazeno 1 - 10
of 64
pro vyhledávání: '"M L Carcangiu"'
Publikováno v:
Histopathology. 49:107-120
This review provides an itemized listing of major diagnostic pitfalls in the field of thyroid tumour pathology, emphasizing the features that the authors have found most useful in their recognition and avoidance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a84169ec408f8a8dae36a19f34b1767
https://doi.org/10.1111/j.1365-2559.2006.02451.x
https://doi.org/10.1111/j.1365-2559.2006.02451.x
Publikováno v:
Veterinary Pathology. 42:223-226
Epithelioid trophoblastic tumor (ETT) is an unusual type of trophoblastic tumor, with features resembling carcinoma. In this study, we describe a 4-year-old cynomolgus monkey ( Macaca fascicularis) showing, at necropsy, a lobulated mass replacing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::babef26644c45796685ef50112ed5ca3
https://doi.org/10.1354/vp.42-2-223
https://doi.org/10.1354/vp.42-2-223
Publikováno v:
International Journal of Gynecologic Cancer. 13:216-222
A pilot study investigated topotecan (Hycamtin, GlaxoSmithKline, Philadelphia, PA), a topoisomerase I inhibitor, in treating uterine serous carcinoma, a typically unresponsive aggressive tumor. Fifteen patients were surgically staged, then treated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50ad91bfa4134c74beea51f09a32bf8c
https://doi.org/10.1136/ijgc-00009577-200303000-00020
https://doi.org/10.1136/ijgc-00009577-200303000-00020
Autor:
G., Tallini, S., Asioli, S., Aubert, M. L., Carcangiu, R. D., Chernock, G., Fellegara, R. A., Ghossein, K., Kakudo, V., LiVolsi, R. V., Lloyd, X., Matias-Guiu, Y. E., Nikiforov, M., Papotti, A., Perren, J., Rosai, M., Sobrinho Simoes
Publikováno v:
WHO/IARC Classification of Tumours; 2017, Vol. 9, p100-103, 4p
Autor:
M L, Carcangiu
Publikováno v:
Pathologica. 95(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fba111cebb077702827df2201de1f3c2
https://pubmed.ncbi.nlm.nih.gov/14989016
https://pubmed.ncbi.nlm.nih.gov/14989016
Publikováno v:
Human pathology. 31(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::423dac730f4dc79aa160aae5c62a0d34
https://pubmed.ncbi.nlm.nih.gov/11203321
https://pubmed.ncbi.nlm.nih.gov/11203321
Publikováno v:
Cancer research. 59(8)
Beta-catenin is an ubiquitously expressed cytoplasmic protein that has a crucial role in both E-cadherin-mediated cell-cell adhesion and as a downstream signaling molecule in the wingless pathway. Stabilization of beta-catenin followed by nuclear tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70f05c73a4ff8b89047c07fd8070cab5
https://pubmed.ncbi.nlm.nih.gov/10213482
https://pubmed.ncbi.nlm.nih.gov/10213482
Publikováno v:
International journal of cancer. 79(5)
High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93cfde352e0ca27200a7ae5ec6bf7e5f
https://pubmed.ncbi.nlm.nih.gov/9761111
https://pubmed.ncbi.nlm.nih.gov/9761111
Autor:
G, Tallini, M, Santoro, M, Helie, F, Carlomagno, G, Salvatore, G, Chiappetta, M L, Carcangiu, A, Fusco
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(2)
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a well-differentiated, clinically indolent, to an undifferentiated, often lethal phenotype. Undifferentiated (anaplastic) thyroid tumors are supposed to be derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::75333ed9e37555f3f134e2c4f9bbe04d
https://pubmed.ncbi.nlm.nih.gov/10589793
https://pubmed.ncbi.nlm.nih.gov/10589793
Publikováno v:
Cancer. 82(9)
Although CA 125 level correlates with response to therapy in patients with serous carcinoma of the ovary, the utility of CA 125 in patients with high risk or metastatic endometrial carcinoma has not been established.CA 125 was tested as a marker of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc8afdd9e7f3ab88a12a6dabef02d5f3
https://pubmed.ncbi.nlm.nih.gov/9576294
https://pubmed.ncbi.nlm.nih.gov/9576294